Literature DB >> 28632304

Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?

Nebojsa Kavaric1, Aleksandra Klisic1, Ana Ninic2.   

Abstract

BACKGROUND: Visceral adiposity index (VAI) and Lipid accumulation product (LAP) are novel visceral adiposity indexes, proposed for the evaluation of cardiometabolic risk in adult population. Considering contradictory results obtained from many studies so far, we aimed to examine the potential benefit of applicability of VAI and LAP, over simple anthropometric indices and traditional lipid parameters in individuals with type 2 diabetes mellitus (DM2).
METHODS: A total of 180 DM2 (of them 50% females) and 119 controls who volunteered to participate in this cross-sectional study were enrolled. Anthropometric and biochemical parameters, as well as blood pressure were obtained. VAI and LAP were calculated.
RESULTS: Multivariate logistic regression analysis showed that high-density lipoprotein cholesterol (HDL-c), (P<.001), waist circumference (WC), (P=.027), age (P=.001), hypolipemic therapy (P=.024), and LAP (P=.005) were independent predictors of DM2 in adjusted models. In Receiver Operating Characteristic curve analysis, used to discriminate subjects with DM2 from those who did not have it, good accuracy of the applied procedures was only achieved with models which were consisted of parameters used in VAI (Body mass index, WC, HDL-c, triglycerides) and LAP (WC, triglycerides) indexes equations, respectively [Area under the curve (AUC)=0.819 and AUC=0.800, respectively], but not with VAI (AUC=0.781) and LAP (AUC=0.784) indexes themselves.
CONCLUSION: Visceral adiposity index and Lipid accumulation product may not be better than parameters that enter its equation in type 2 diabetes prediction.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  lipid accumulation product; obesity; type 2 diabetes mellitus; visceral adiposity index

Mesh:

Substances:

Year:  2017        PMID: 28632304      PMCID: PMC6816927          DOI: 10.1002/jcla.22283

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  36 in total

1.  Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.

Authors:  Ajay K Gupta; Bjorn Dahlof; Joanna Dobson; Peter S Sever; Hans Wedel; N R Poulter
Journal:  Diabetes Care       Date:  2008-01-30       Impact factor: 19.112

2.  The Visceral Adiposity Index: Relationship with cardiometabolic risk factors in obese and overweight postmenopausal women--a MONET group study.

Authors:  Belinda Elisha; Virginie Messier; Antony Karelis; Lise Coderre; Sophie Bernard; Denis Prud'homme; Rémi Rabasa-Lhoret
Journal:  Appl Physiol Nutr Metab       Date:  2013-03-15       Impact factor: 2.665

3.  Visceral Adiposity Index Is Associated with Pre-Diabetes and Type 2 Diabetes Mellitus in Chinese Adults Aged 20-50.

Authors:  Peng Ju Liu; Fang Ma; Hui Ping Lou; Yu Chen
Journal:  Ann Nutr Metab       Date:  2016-05-04       Impact factor: 3.374

4.  Relationship between Cystatin C, Retinol-binding Protein 4 and Framingham Risk Score in Healthy Postmenopausal Women.

Authors:  Aleksandra Klisic; Jelena Kotur-Stevuljevic; Nebojsa Kavaric; Marija Matic
Journal:  Arch Iran Med       Date:  2016-12       Impact factor: 1.354

5.  Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study.

Authors:  Mohammadreza Bozorgmanesh; Farzad Hadaegh; Fereidoun Azizi
Journal:  Lipids Health Dis       Date:  2010-05-10       Impact factor: 3.876

6.  Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.

Authors:  D Wiltgen; I G Benedetto; L S Mastella; P M Spritzer
Journal:  Hum Reprod       Date:  2009-03-27       Impact factor: 6.918

7.  The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison.

Authors:  Henry S Kahn
Journal:  BMC Cardiovasc Disord       Date:  2005-09-08       Impact factor: 2.298

8.  Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.

Authors:  Dongxue Dai; Ye Chang; Yintao Chen; Shuang Chen; Shasha Yu; Xiaofan Guo; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2016-12-13       Impact factor: 3.390

9.  Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly.

Authors:  Anna Karla Carneiro Roriz; Luiz Carlos Santana Passos; Carolina Cunha de Oliveira; Michaela Eickemberg; Pricilla de Almeida Moreira; Lílian Ramos Sampaio
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

10.  Applicability of visceral adiposity index in predicting metabolic syndrome in adults with obstructive sleep apnea: a cross-sectional study.

Authors:  Gong-Ping Chen; Jia-Chao Qi; Bi-Ying Wang; Xin Lin; Xiao-Bin Zhang; Jian-Ming Zhao; Xiao Fang Chen; Ting Lin; Dong-Dong Chen; Qi-Chang Lin
Journal:  BMC Pulm Med       Date:  2016-03-01       Impact factor: 3.317

View more
  14 in total

1.  Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?

Authors:  Nebojsa Kavaric; Aleksandra Klisic; Ana Ninic
Journal:  J Clin Lab Anal       Date:  2017-06-20       Impact factor: 2.352

2.  Children's Lipid Accumulation Product Combining Visceral Adiposity Index is a Novel Indicator for Predicting Unhealthy Metabolic Phenotype Among Chinese Children and Adolescents.

Authors:  Yangyang Dong; Ling Bai; Rongrong Cai; Jinyu Zhou; Wenqing Ding
Journal:  Diabetes Metab Syndr Obes       Date:  2021-11-23       Impact factor: 3.168

3.  Micro-ribonucleic acid modulation with oxidative stress and inflammation in patients with type 2 diabetes mellitus - a review article.

Authors:  Aleksandra Klisic; Irena Radoman Vujacic; Jelena Munjas; Ana Ninic; Jelena Kotur-Stevuljevic
Journal:  Arch Med Sci       Date:  2022-04-10       Impact factor: 3.707

4.  Xanthine oxidase and uric acid as independent predictors of albuminuria in patients with diabetes mellitus type 2.

Authors:  Aleksandra Klisic; Gordana Kocic; Nebojsa Kavaric; Milovan Jovanovic; Verica Stanisic; Ana Ninic
Journal:  Clin Exp Med       Date:  2017-12-06       Impact factor: 3.984

5.  Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Milovan Jovanovic; Elvir Zvrko; Verica Skerovic; Andjelka Scepanovic; Darko Medin; Ana Ninic
Journal:  J Res Med Sci       Date:  2017-11-28       Impact factor: 1.852

6.  Cardiovascular Risk Estimated by UKPDS Risk Engine Algorithm in Diabetes.

Authors:  Nebojsa Kavaric; Aleksandra Klisic; Ana Ninic
Journal:  Open Med (Wars)       Date:  2018-12-31

7.  Association of lipid accumulation product trajectories with 5-year incidence of type 2 diabetes in Chinese adults: a cohort study.

Authors:  Guangyu Yan; Fei Li; Christelle Elia; Yating Zhao; Jiangguang Wang; Zhiheng Chen; Hong Yuan; Yao Lu
Journal:  Nutr Metab (Lond)       Date:  2019-10-21       Impact factor: 4.169

8.  Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Verica Stanisic; Sanja Vujcic; Vesna Spasojevic-Kalimanovska; Ana Ninic; Jelena Kotur-Stevuljevic
Journal:  Arch Med Sci       Date:  2019-08-27       Impact factor: 3.318

9.  Retinol-binding protein 4 versus albuminuria as predictors of estimated glomerular filtration rate decline in patients with type 2 diabetes.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Ana Ninic
Journal:  J Res Med Sci       Date:  2018-05-30       Impact factor: 1.985

10.  Cardiovascular Risk Assessed by Reynolds Risk Score in Relation to Waist Circumference in Apparently Healthy Middle-Aged Population in Montenegro.

Authors:  Aleksandra Klisić; Nebojša Kavarić; Bojko Bjelaković; Milovan Jovanović; Elvir Zvrko; Verica Stanišić; Ana Ninić; Anđelka Šćepanović
Journal:  Acta Clin Croat       Date:  2018-03       Impact factor: 0.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.